Pregnenolone succinate is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Formula 405 and 3beta-Hydroxypregn-5-en-20-one 3-(hydrogen succinate). Its PubChem CID is 10070529.
Pregnenolone succinate
| CAS No | 4598-67-8 |
|---|---|
| Molecular Formula | C25H36O5 |
| Molecular Weight | 416.5 g/mol |
| Synonyms | 4-[[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pregnenolone succinate is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin.
The listed CAS number is 4598-67-8.
The listed molecular formula is C25H36O5.
The listed molecular weight is 416.5 g/mol.
4-[[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid.
The source lists Formula 405 and 3beta-Hydroxypregn-5-en-20-one 3-(hydrogen succinate).